CD8A and neoplasm: The increase in number of CD8+/GrzB+ cytotoxic T cells in post-treatment tumour samples was also associated with a lower likelihood of local recurrence and higher regression grade, suggesting that CD8+/GrzB+ T cells may promote a better outcome and contribute to local tumour control.